Our CEO joined @MidasLetter to discuss why we believe NP-120 (Ifenprodil) could potentially be used as a treatment for #COVID19.

Watch the full interview to learn more: https://t.co/7333PMgBDN

$AGN.CN $AGW $AGNPF #Pharma #Stocks #Investing #Biotech https://t.co/NiKRWqmEwW